Showing results (561-570 of 2,914) with videos related to

Sort By:
Pageof 292
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolismNicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 12, 2022
The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic ArthritisBryce A Binstadt, Peter A Nigrovic
Arthritis & Rheumatology (Hoboken, N.J.)|November 2, 2021
Defibrotide Inhibits Antiphospholipid Antibody-Mediated Neutrophil Extracellular Trap Formation and Venous ThrombosisRamadan A Ali, Shanea K Estes, Alex A Gandhi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 2, 2021
Association Between Gut Microbiota and Elevated Serum Urate in Two Independent CohortsJie Wei, Yuqing Zhang, Nicola Dalbeth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2018
Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis PatientsKristine Germar, Cynthia M Fehres, Hans U Scherer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2018
Adoptive Treg Cell Therapy in a Patient With Systemic Lupus ErythematosusMaria Dall'Era, Mariela L Pauli, Kelly Remedios, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2019
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid ArthritisFrançois Santinon, Maxime Batignes, Majda Lyna Mebrek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Functional Characterization of the Osteoarthritis Genetic Risk Residing at ALDH1A2 Identifies rs12915901 as a Key Target VariantColin Shepherd, Dongxing Zhu, Andrew J Skelton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 16, 2019
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid ArthritisGeorge D Kitas, Peter Nightingale, Jane Armitage, et al.
Pageof 292